Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Net Margin (2019 - 2025)

Historic Net Margin for Neurogene (NGNE) over the last 5 years, with Q1 2025 value amounting to 28491.25%.

  • Neurogene's Net Margin rose 256572000.0% to 28491.25% in Q1 2025 from the same period last year, while for Sep 2025 it was 108471.25%, marking a year-over-year increase of 1301489600.0%. This contributed to the annual value of 8184.43% for FY2024, which is N/A changed from last year.
  • As of Q1 2025, Neurogene's Net Margin stood at 28491.25%, which was up 256572000.0% from 2014.27% recorded in Q2 2024.
  • Neurogene's Net Margin's 5-year high stood at 408700.0% during Q1 2023, with a 5-year trough of 2014.27% in Q2 2024.
  • Moreover, its 3-year median value for Net Margin was 15662.65% (2024), whereas its average is 109502.76%.
  • In the last 5 years, Neurogene's Net Margin plummeted by 2000000000bps in 2024 and then soared by 256572000bps in 2025.
  • Neurogene's Net Margin (Quarter) stood at 408700.0% in 2023, then crashed by -100bps to 2014.27% in 2024, then skyrocketed by 1514bps to 28491.25% in 2025.
  • Its last three reported values are 28491.25% in Q1 2025, 2014.27% for Q2 2024, and 2834.05% during Q1 2024.